T2	Participants 355 509	In this study, 97 patients aged 6 to 17 years with ADHD and ASD were randomly assigned to double-blind treatment with 1.2 mg/kg/day atomoxetine or placebo
T3	Participants 226 321	attention-deficit/hyperactivity disorder (ADHD) in patients with autism spectrum disorder (ASD)
T1	Participants 66 158	attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.
T4	Participants 1756 1781	ADHD patients without ASD
T5	Participants 1614 1648	ADHD symptoms in patients with ASD
T6	Participants 1889 1923	ADHD Symptoms in Children with ASD
